The diagnostic abilities of these exosomal miRNAs in identifying IPMN and early PC surpass those of conventional markers like carcinoembryonic antigen (CEA) and cancer antigen 19-9 (CA19-9). This evidence concerns the gene CEACAM5 and pachyonychia congenita.